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Ionotropic glutamate receptors (iGluRs) underlie rapid, excitatory synaptic signaling throughout the CNS.
After years of intense research, our picture of iGluRs has evolved from thembeing companionless in the post-
synaptic membrane to them being the hub of dynamic supramolecular signaling complexes, interacting with
an ever-expanding litany of other proteins that regulate their trafficking, scaffolding, stability, signaling, and
turnover. In particular, the discovery that transmembrane AMPA receptor regulatory proteins (TARPs) are
AMPA receptor auxiliary subunits that are critical determinants of their trafficking, gating, and pharmacology
has changed the way we think about iGluR function. Recently, a number of novel transmembrane proteins
have been uncovered that may also serve as iGluR auxiliary proteins. Here we review pivotal developments
in our understanding of the role of TARPs in AMPA receptor trafficking and gating, and provide an overview of
how newly discovered transmembrane proteins expand our view of iGluR function in the CNS.Introduction
The control of neuronal excitability is accomplished through the
finely tuned spatial and temporal regulation of ion flow across
cell membranes. Two broad classes of ion channels are critical
determinants ofmembrane excitability in neurons: voltage-gated
and ligand-gated channels. Many if not all voltage-gated chan-
nels are associated with smaller auxiliary b subunits, which can
affect where, when, and how the channel gets activated. These
b subunits are often stable components of the channel complex
and can affect every aspect of ion channel biology, including
forward trafficking through the ER, surface delivery, targeting
to specific subcellular compartments, and gating kinetics
(Arikkath and Campbell 2003; Vacher et al., 2008; Dai et al.,
2009; Pongs and Schwarz, 2010). Ligand-gated ion channels,
or ionotropic receptors, include gamma amino-butyric acid
(GABAA) receptors, nicotinic acetylcholine receptors (nAChRs),
and a variety of glutamate receptor subtypes, including
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA),
N-methyl-D-aspartic acid (NMDA), and kainate (KA) receptor
subtypes. Until recently, these ligand-gated channels were
thought to differ fundamentally from voltage-gated channels
because, despite considerable effort, no transmembrane auxil-
iary subunits had been identified. This picture changed with
the discovery that the small transmembrane protein stargazin
or g-2 (Letts et al., 1998) is critical for the functional expression
of AMPA receptors (AMPARs) in cerebellar granule neurons
(CGNs) (Chen et al., 1999, 2000; Hashimoto et al., 1999). Starga-
zin has since been shown to be the founding member of a family
of transmembrane AMPAR regulatory proteins (TARPs) (Tomita
et al., 2003), which exhibit remarkable phylogenetic conserva-
tion (Wang et al., 2008). The discovery of TARPs provided
a missing link in relating the behavior of AMPARs expressed178 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.alone in heterologous systems to that in native neurons, and
has inspired the search for other transmembrane auxiliary
subunits. Recent database mining and various proteomic and
screening methods have unearthed several unrelated trans-
membrane proteins that may also serve as auxiliary AMPAR
subunits. Furthermore, emerging work indicates that KA recep-
tors (KARs), and perhaps also NMDA receptors (NMDARs), are
similarly regulated by transmembrane auxiliary subunits. Thus
ligand-gated ion channelsmay now rival voltage-gated ion chan-
nels with regard to the extraordinary diversity and richness that
auxiliary subunits impart to their function.
Before going any further, it is worth asking how we define
a bona fide transmembrane auxiliary subunit. Is any transmem-
brane protein that interacts with iGluRs an auxiliary subunit?
What about a protein that interacts with iGluRs as a chaperone
during the early stages of biogenesis, but plays no role in the
function of themature protein? Our working definition of an iGluR
transmembrane auxiliary subunit is that it avidly and selectively
binds to mature iGluRs as part of a stable complex at the cell
surface, that it can modulate the functional characteristics of
iGluRs, and that it may also mediate surface trafficking and/or
targeting to specific subcellular compartments, such as
synapses. The rapidly expanding host of candidate iGluR trans-
membrane auxiliary subunits raises fascinating questions about
the broad role of auxiliary subunits in ion channel function, and
specifically about the biology of iGluRs. For example, why are
there so many TARP family members with largely redundant
roles in trafficking and gating? How do the TARPs interact with
newly discovered transmembrane proteins—do they play unique
roles within supramolecular complexes or are they involved in
different phases of the lifecycle of iGluRs? In what way do these
often structurally unrelated transmembrane proteins display
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Figure 1. Major Structural Domains of AMPARs and TARPs
Illustration of the structural features of a closely apposed individual GluA
subunit (left) and a canonical TARP auxiliary subunit (right). The GluA subunit of
a tetrameric AMPAR is composed of a large extracellular N-terminal domain
(NTD), the ligand-binding core, transmembrane domains, linker regions, and
several intracellular domains including the C-terminal tail (CTD). Agonists such
as glutamate (yellow) bind within the ligand-binding core to mediate channel
opening. The Q/R site (magenta) is the narrowest constriction of the AMPAR
pore and is an important determinant of its functional properties. The TARP
auxiliary subunit (right) consists of four transmembrane domains with a large
extracellular loop that is essential for TARP modulation of AMPAR gating. The
tip of the TARP CTD contains a PDZ bindingmotif (red), which is known to bind
to PDZ domain-containing proteins such as PSD-95, and which is essential for
the synaptic targeting of AMPARs.
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some of these broader questions, this review will summarize
key developments in our understanding of the TARP family
before moving on to a discussion of recent work on TARPs
and the ever-growing list of other AMPAR, NMDAR, and KAR
transmembrane auxiliary subunits. Interested readers are also
directed to several excellent reviews on the stargazer mouse
(Letts, 2005; Osten and Stern-Bach, 2006) and TARPmodulation
of AMPAR trafficking and gating (Nicoll et al., 2006; Sager et al.,
2009a; Payne, 2008; Coombs and Cull-Candy, 2009; Milstein
and Nicoll, 2008; Kato et al., 2010; Tomita, 2010; Dı´az, 2010b).
The iGluR Family and Its Regulation by Intracellular
Protein-Protein Interactions
Fast excitatory neurotransmission in the CNS is primarily medi-
ated by three classes of tetrameric iGluRs: AMPARs (GluA1–4),
NMDARs (GluN1, GluN2A–D, GluN3A–B), and KARs (GluK1–5),
alongwith a fourth, lesswell-characterized, class, the d receptors
(GluD1–2) (Collingridge et al., 2009). Sequence homology
between and within classes suggests that the general architec-
ture of iGluRs is modular and shares several common features
(Figure 1). Aside from sequence and structural differences,
iGluRs are distinguished by their differential pharmacology,
unique activation, deactivation and desensitization kinetics,
selective permeability, single-channel properties, and the unique
roles they play in different forms of both neuronal and glial
signaling (Wollmuth and Sobolevsky, 2004; Mayer, 2005; Tray-
nelis et al., 2010). To a large extent, iGluRs determine the shape
of synaptic currents at glutamatergic synapses. For AMPARs,
the kinetics of deactivation and desensitization, in addition to
other factors including subunit composition, RNA editing, and
alternative splicing, are key regulators of the amplitude andkinetics of synaptic currents and determine their role in synaptic
integration, signaling, and plasticity (Jonas, 2000). Yet, rigorous
comparisons of AMPAR gating kinetics found recombinant
AMPARs (Mosbacher et al., 1994) to be faster than those of
native receptors (Colquhoun et al., 1992). In addition, the gating
properties analyzed at the single-channel level in heterologous
systems (Swanson et al., 1997) failed to match those recorded
from native receptors (Wyllie et al., 1993). A similar lack of
congruence existed between the kinetics of native (Castillo
et al., 1997) and heterologously expressed KARs (Swanson
and Heinemann, 1998). These findings suggested that additional
proteins might associate with native receptors and alter their
gating.
Over the past 20 years, tremendous progress has been made
toward identifying proteins that interact with iGluRs, thus unrav-
eling the molecular machinery that regulates the trafficking and
function of iGluRs. The picture that emerges is that iGluRs are
but one component of larger-scale, multimeric complexes.
This is of particular interest in the context of the postsynaptic
density (PSD) of excitatory synapses—a vast web of interacting
proteins that comprise large and dynamic supramolecular
assemblies (Scannevin and Huganir, 2000; Grant et al., 2005;
Yamauchi, 2002: Feng and Zhang, 2009). The C-terminal tails
(CTDs) of iGluRs have been a particular focus of attention in
this regard, because they exhibit a great deal of diversity in
length and sequence, and display numerous consensus sites
for phosphorylation and a variety of protein-protein interactions.
A myriad of cytosolic proteins have been identified that interact
with the CTDs of iGluRs and regulate their membrane trafficking,
anchoring at synapses, and involvement in intracellular signaling
cascades. Depending on the particular class of iGluR, such
cytoplasmic proteins include postsynaptic density-95/discs
large/zona occludens-2 (PDZ) domain-containing proteins
(such as GRIP/ABP, PICK1, and a variety of membrane-associ-
ated guanylate kinase or MAGUK proteins), cytoskeleton-inter-
acting or scaffolding proteins (such as a-actinin, protein 4.1,
and spectrin), and the ATPase NSF (Song and Huganir, 2002;
Malinow andMalenka, 2002; Bredt andNicoll, 2003; Collingridge
et al., 2004; Kim and Sheng, 2004; Derkach et al., 2007; Lau and
Zukin, 2007; Elias and Nicoll, 2007). The CTDs of iGluRs are also
subject to phosphorylation by a variety of kinases such as
protein kinase C (PKC), protein kinase A (PKA), and calcium-
calmodulin kinase II (CaMKII), and by tyrosine kinases such as
src and fyn (Boehm and Malinow, 2005; Lee, 2006).
The stargazer Mutant Mouse and a New Family
of AMPAR Regulatory Proteins
The first bona fide transmembrane auxiliary subunit of an iGluR
wasdiscovered through thecharacterizationof stargazer, a spon-
taneousmutation in an inbredmouse line, originally distinguished
by its striking behavioral phenotype—dyskinesia, severe ataxia,
characteristic head-tossing, and frequent spike-wave
discharges (SWDs), reminiscent of absence epilepsy in humans
(Noebels et al., 1990). Genetic mapping revealed that the
stargazer mutation is attributable to a single recessive mutation
on mouse chromosome 15 (Letts et al., 1997). Subsequent
positional cloning showed that the locus of themutation encodes
stargazin—a novel, brain-specific, low-molecular weight,Neuron 70, April 28, 2011 ª2011 Elsevier Inc. 179
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Figure 2. The TARP Family of
Transmembrane AMPAR Auxiliary Subunits
and Their Relatives
(A) Dendrogram illustrating the approximate
phylogenetic relationships between all known
TARP auxiliary subunits and several related
proteins. The TARPs include stargazin (g-2), g-3,
g-4, g-5, g-7, and g-8. The TARPs are homologous
to the skeletal muscle voltage-gated calcium
channel auxiliary subunit g-1, as well as g-6.
Claudin-1 is a member of the claudin family of
tight-junction proteins. The more distantly related
proteins from C. elegans, SOL-1, STG-1, and
STG-2, are necessary for the function of GLR-1,
the AMPAR homolog in C. elegans. The dendro-
gram is based on sequence alignment of amino
acid sequences using ClustalW. All protein
sequences are from mouse unless otherwise
noted (C. elegans).
(B) Bar diagrams showing the predicted domain
structures of the TARPs (both type I and type II),
in addition to C. elegans STG-1/2 and SOL-1
for comparison. Noteworthy are the four large
extracellular CUB domains of SOL-1 and the
approximate locations of sites of posttranslational
modification.
(C) Illustration of the proposed secondary struc-
tures of the proteins shown in (B). Top is extra-
cellular, bottom is intracellular.
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gated calcium channel (VGCC) subunit g-1, hence its alternative
name, g-2 (Letts et al., 1998) (Figure 2). Despite the role of g-1 in
modulating the functional properties of VGCCs in skeletal muscle
(Jay et al., 1990), stargazin displays only subtle changes in the
voltage dependence of activation and inactivation of VGCCs
when coexpressed in heterologous systems (Letts et al., 1998;
Klugbauer et al., 2000; Kang et al., 2001, 2006; Rousset et al.,
2001). Instead, the weight of evidence is in favor of stargazin
being essential for the regulation of AMPARs, first demonstrated
in the cerebellum. In the stargazer mouse, AMPAR-mediated
synaptic currents at the glutamatergic synapse between mossy
fibers and CGNs, as well as extrasynaptic currents, are largely
absent. NMDAR-mediated responses are normal, however, indi-
cating that excitatory synapses generally develop properly and180 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.are capable of releasing glutamate (Chen
et al., 1999, 2000; Hashimoto et al.,
1999). Chen and colleagues subsequently
transfected stargazer CGNs with full-
length recombinant stargazin and found
that both synaptic and extrasynaptic
AMPAR-mediated responses could be
reconstituted, suggesting that stargazin
plays a critical role in the trafficking and
ultimate synaptic targeting of AMPARs
(Chen et al., 2000).
Stargazin is neither confined to the
cerebellum nor alone in its ability to
modulate AMPAR-mediated transmis-
sion. Database mining revealed that star-
gazin is a member of an extended family
of tetraspanning proteins that includesg-3, g-4, g-5, g-6, g-7, g-8, and members of the claudin
protein family. These homologous proteins exhibit widespread
expression within the CNS (Burgess et al., 1999, 2001; Klugba-
uer et al., 2000; Moss et al., 2002). Phylogenetic analyses of
the primary sequences showed that the family of g subunit
proteins can be divided into subgroups based on homology,
with stargazin, g-3, g-4, and g-8 forming one highly homologous
group, g-5 and g-7 forming another, and g-1 and g-6 being yet
another (Klugbauer et al., 2000; Burgess et al., 2001; Tomita
et al., 2003) (Figure 2A). Does the clustering on the basis of
sequence alignment have functional implications? Indeed, star-
gazin, g-3, g-4, and g-8 can rescue AMPAR-mediated surface
currents in stargazer CGNs, whereas g-1, g-5, and claudin-1
fail to do so. As such, stargazin, g-3, g-4, and g-8 were initially
classified as TARPs (Tomita et al., 2003). With the discovery
Neuron
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AMPAR trafficking and gating (Kato et al., 2007, 2008; Soto
et al., 2009), the TARP family was later expanded and subclassi-
fied into canonical or type I TARPs (stargazin, g-3, g-4, and g-8)
and type II TARPs (g-5 and g-7) (Kato et al., 2010) (Figure 2B
and Table 1). The basis for this subclassification as well as the
differential expression patterns and roles of these various
TARP family members will be explored later in this review.
TARPs Form an Integral Component of Native
AMPAR Complexes
Multiple lines of compelling evidence suggest that TARPs avidly
and selectively bind to native AMPAR subunits in the brain and
are key components of the AMPAR complex at every point in
its life cycle. Initial coimmunoprecipitation experiments found
that stargazin associates with multiple GluA subunits in both
heterologous cells (Chen et al., 2000) and brain extracts (Tomita
et al., 2003, 2004; Fukata et al., 2005). Vandenberghe and
coworkers analyzed cerebellar extracts using blue native gel
electrophoresis and found that AMPAR complexes migrate as
two distinct bands—a low and a high molecular weight band.
Stargazin comigrates exclusively with the heavier band, which
is absent in cerebellar extracts from stargazer mice. These data
suggest that stargazin is stably associated with tetrameric
AMPARs, and not monomers or dimers. Under these conditions,
it is noteworthy that other AMPAR CTD-interacting proteins,
including GRIP, PICK1, and NSF, are undetectable in native
AMPAR complexes, suggesting that their interactions may be
less stable and/or more transient than AMPAR-stargazin interac-
tions.On thebasis of thesebiochemical data, stargazinwasdesig-
nated as a bona fide AMPAR auxiliary subunit (Vandenberghe
et al., 2005a). Furthermore,mass spectrometric analyses revealed
the presence of multiple TARP family members within native
AMPARcomplexes fromsolubilized rodentbrain preparations (Fu-
kata et al., 2005; Nakagawa et al., 2005; Schwenk et al., 2009).
A longstanding, and as yet unresolved, question remains
regarding the structural basis for AMPAR-TARP interactions.
Single-particle electron microscopic approaches have been
valuable in showing that TARP family members substantially
contribute to the transmembrane density seen in 3D reconstruc-
tions of individual complexes, isolated from whole rat brain
(Nakagawa et al., 2005, 2006). Such close apposition of the
transmembrane domains of AMPARs and TARPs indirectly
suggests a transmembrane interaction, but it could also be
a consequence of more specific conjunctions at the level of
the intracellular and extracellular domains. Mutagenesis and
domain swapping experiments revealed specific regions of star-
gazin that interact with AMPARs. The first extracellular loop and
regions within the CTD are especially important for AMPAR
binding (Tomita et al., 2004) (Figure 1). The first extracellular
loop of stargazin is essential for the modulation of AMPAR
gating, but not trafficking. Conversely, the stargazin CTD is crit-
ical for AMPAR trafficking and aspects of gating (Tomita et al.,
2004, 2005b, Turetsky et al., 2005, Bedoukian et al., 2006; Sager
et al., 2009b; Milstein and Nicoll, 2009). Subsequent work
showed that regions within the AMPAR ligand-binding core,
but not the amino terminal domain (NTD), are essential for
TARP modulation of gating (Tomita et al., 2007a). Furthermore,TARP effects on gating kinetics depend on the Q/R site within
the AMPAR pore, suggesting an indirect role for the pore, and
possibly the transmembrane domains, in determining TARP
binding (Ko¨rber et al., 2007a). Together, these studies suggest
that TARPs bind to AMPARs in a complex and distributed
fashion, with a special role for the first extracellular loop, likely
through a direct interaction with the AMPAR ligand-binding
core. Although the crystallization of AMPAR structural domains,
such as the ligand-binding core (Armstrong et al., 1998), as well
as the full AMPAR tetramer (Sobolevsky et al., 2009), repre-
sented quantum leaps in our understanding of iGluR structure
and function, the exact nature of the interaction between
AMPARs and TARPs awaits either the crystal structure of a
TARP or the cocrystallization of an AMPAR-TARP complex.
Aside from determining the structural basis for AMPAR-TARP
interactions, persistent questions remain regarding TARP stoi-
chiometry. How many TARP molecules are associated with
single-AMPAR complexes in native systems? Can the trafficking
and gating effects of TARPs be tuned by differences in stoichi-
ometry? The dose dependence of TARP gating effects, reflected
in miniature excitatory postsynaptic current (mEPSC) decay,
provided the first tantalizing hint that AMPAR-TARP interactions
may exhibit variable stoichiometry (Milstein et al., 2007). Since
then, TARPmodulation of KA efficacy has been a valuable metric
for TARP stoichiometry in both heterologous and native systems.
Fusion proteins, in which GluA subunits are bound to various
TARP family members through linker domains, provide
AMPAR-TARP complexes with defined stoichiometry. Using
these constructs to calibrate KA efficacy in heterologous cells,
AMPARs are estimated to associate with either two or four
TARPs, suggesting a degree of cooperativity in TARP binding.
TARP stoichiometry, suggested by KA efficacy, was subse-
quently found to differ among hippocampal cell types, suggest-
ing that gating effects could be modulated by differential TARP
expression (Shi et al., 2009). However, biochemical data has
shown that AMPARs are capable of associating with one, two,
three, or four stargazin molecules depending on its expression
level, contradicting the notion of cooperative binding. In addition,
AMPARs in CGNs were estimated to associate with only one
stargazin molecule, which is sufficient to modulate KA efficacy
(Kim et al., 2010). These contrasting results may be attributed,
in part, to cell-type-specific differences in TARP subtypes and
expression level. Clearly, further quantitative work will be
required to clarify the possible TARP subtype and cell-type-
specific regulation of stoichiometry. More broadly, there remains
the possibility that TARP stoichiometry is not fixed throughout
the lifecycle of an AMPAR, but rather that it can be dynamically
regulated. Evidence that AMPAR-TARP complexes can undergo
acute, agonist-dependent dissociation (Tomita et al., 2004), and
can modify paired-pulse ratio (PPR) in hippocampal neurons
(Morimoto-Tomita et al., 2009), suggests that dynamic regulation
is possible, but its ultimate impact on postsynaptic AMPAR
function remains to be elucidated.
TARPs and AMPAR Biogenesis
The AMPAR lifecycle begins in the ER through the sequential
assembly of homodimers or heterodimers followed by the dimer-
ization of dimers. Tetramers are subsequently exported from theNeuron 70, April 28, 2011 ª2011 Elsevier Inc. 181
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subjected to posttranslational modification in the form of phos-
phorylation and glycosylation (Greger et al., 2007; Ziff, 2007).
From early work on stargazin, it was unclear whether the lack of
surface and synaptic AMPARs observed in stargazer CGNs
(Chen et al., 2000) could be attributable to a role for stargazin
as a chaperone during these early biosynthetic events, specific
effects on surface expression and synaptic targeting of AMPARs,
or both. In stargazerCGNs, despite only aminor reduction in total
GluA2 protein in whole cerebella, GluA2 surface expression is
dramatically reduced. A large proportion of the remaining
GluA2 exhibits immature ER-type glycosylation, implying that
GluA2 is unable to exit the ER and fully mature in stargazer
CGNs. This result suggested that stargazin is involved in the early
stages of GluA biosynthesis (Tomita et al., 2003). In fact, previous
work showed that the majority of GluA protein, expressed in
heterologous cells in the absence of TARPs, is also incompletely
glycosylated and accumulates in intracellular pools, presumably
corresponding to the ER (Hall et al., 1997). Fluorescence reso-
nance energy transfer (FRET) experiments suggested that TARPs
may facilitate ER export by blocking ER-retention sites on the
AMPAR (Bedoukian et al., 2006), although later work demon-
strates that the stargazin CTD contains a region that is essential
for forward traffic through the ER and Golgi. Furthermore, the
stargazin CTD can be tacked onto unrelated receptors, and not
only mediates their ER export, but directs their localization to
specific membrane compartments (Bedoukian et al., 2008).
Additional evidence that stargazin has a role to play in AMPAR
biosynthesis and ER export are experiments showing that induc-
tion of the unfolded protein response (UPR), a homeostatic
response to the accumulation of unfolded or misassembled
protein in the ER, can boost GluA1 surface expression in heterol-
ogous cells in a way that mimics and occludes the effect of star-
gazin. In addition, stargazer CGNs exhibit enhanced UPR,
compatible with the notion that, in the absence of stagazin,
AMPAR subunits may be incompletely folded or assembled
and stuck in the ER (Vandenberghe et al., 2005b). Consistent
with stargazin being exclusively associated with tetrameric
AMPARs (Vandenberghe et al., 2005a; Shanks et al., 2010),
TARPs are likely to be incorporated into nascent AMPAR
complexes at some point between tetramerization and ER
export. The role that TARPs play, if any, in protein folding, RNA
editing, and subunit assembly at an earlier stage in AMPAR
biogenesis remains to be determined. However, given that there
is no clear enhancement in the levels of GluA monomers and
dimers in cerebellar extracts from stargazermice, the possibility
that TARPs influence dimerization or tetramerization in the ER
seems unlikely (Vandenberghe et al., 2005a). An intriguing possi-
bility is thatmembers of the newly characterizedAMPARauxiliary
proteins, the Cornichon homologs (CNIHs), also have an impor-
tant role to play in early steps in AMPAR biogenesis, considering
their well-established role in ER export in other systems (Roth
et al., 1995; Schwenk et al., 2009; Shi et al., 2010).
The Role of TARPs in AMPAR Surface Trafficking
and Synaptic Targeting
In both heterologous systems and neurons, TARPs dramatically,
selectively, and dose-dependently enhance the surface expres-182 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.sion of AMPARs. In stargazer CGNs, both synaptic and extrasy-
naptic AMPARs are essentially absent (Chen et al., 1999; Hashi-
moto et al., 1999) but can be restored by transfection with
full-length stargazin (Chen et al., 2000). Other members of the
type I TARPs, g-3, g-4, and g-8, but not g-7 and g-5, are able
to rescue AMPAR surface expression when expressed in
stargazer CGNs (Tomita et al., 2003). This effect was further
characterized in heterologous systems where coexpression of
various TARP family members along with GluA subunits greatly
enhanced AMPAR surface expression as measured by the
amplitude of agonist-evoked currents and a surface biotinylation
assay. This effect is specific to AMPARs because TARPs are
unable to traffic structurally related KARs (Chen et al., 2003;
Yamazaki et al., 2004; Tomita et al., 2004, 2005b; Priel et al.,
2005). Furthermore, the enhancement of surface expression by
stargazin is not the result of inhibition of constitutive AMPAR
endocytosis (Vandenberghe et al., 2005b). The type II TARP
g-7, but not g-5, was later shown to enhance glutamate-evoked
AMPAR currents in HEK293 cells in a subunit-specific manner
(Kato et al., 2007, 2008), but had a very limited ability to do so
in stargazer CGNs (Kato et al., 2007) (Table 1).
Importantly, TARPs direct AMPAR trafficking in neurons by
specifically targeting them to synapses through PDZ binding
motifs located in the last four residues of their cytosolic CTDs.
Transfection of stargazer CGNs with a construct encoding
a mutant stargazin with the last four residues missing (starga-
zinDC) results in the reconstitution of AMPAR surface expres-
sion, but not synaptic trafficking (Chen et al., 2000). The PDZ
binding motif of stargazin binds to PDZ domain-containing scaf-
folding proteins like PSD protein-95 (PSD-95) and related
members of the MAGUK protein family (Chen et al., 2000;
Schnell et al., 2002; Dakoji et al., 2003), which are pivotal compo-
nents of the PSD and essential for AMPAR synaptic targeting
(Kim and Sheng, 2004; Elias and Nicoll, 2007). Because
PSD-95 and PDS-93 do not directly bind to AMPARs, TARPs
play an essential intermediary role in anchoring and stabilizing
AMPARs at synapses. Furthermore, TARP-dependent AMPAR
clustering is dependent on PSD-95 palmitoylation (El-Husseini
et al., 2002). Bats and coworkers showed, using single-particle
quantum dot and fluorescence recovery after photobleaching
(FRAP) imaging in cultured hippocampal neurons, that TARPs
regulate the lateral diffusion of AMPARs between extrasynaptic
and synaptic sites. They demonstrated that the disruption of
stargazin-PSD-95 interactions prevents clustering of freely
diffusible AMPAR-stargazin complexes at PSDs (Bats et al.,
2007). Furthermore, a recent chemical-genetic approach
demonstrated that the introduction of biomimetic ligands, which
compete for both stargazin CTDs and PSD-95 binding sites, can
acutely disrupt stargazin-PSD-95 interactions in cultured hippo-
campal neurons and enhance the surface mobility of AMPARs
(Sainlos et al., 2011).
The modulatory influence of TARPs on AMPAR trafficking is
itself subject to modulation through posttranslational modifica-
tion. In particular, the CTDs of type I TARPs are studded with
serine, threonine, and tyrosine residues that are substrates for
phosphorylation. The threonine within the PDZ binding motif of
stargazin can be phosphorylated by cAMP-dependent PKA,
which disrupts its ability to bind to PSD-95. Furthermore,
Table 1. Modulation of AMPA Receptor Surface Trafficking and Synaptic Targeting and Gating by Mammalian Transmembrane Auxiliary Proteins
Type I TARPs Type II TARPs Candidate AMPAR Auxiliary Proteins
stargazin (g-2)a g-3b g-4c g-8d g-5e g-7f CNIH-2/3g CKAMP44h SynDig1i
PDZ binding motif Class I-TTPV Class I-TTPV Class I-TTPV Class I-TTPV Atypical-SSPC Atypical-TSPC none Class II-EVTV none
Surface trafficking
of AMPARs
[ [ [[ [[ 4 [ 4 YY unknown
Enriched at
synapses/PSD
fractions
[[ [[ [[ [[ 4 [ [ [[ [[
Synaptic targeting
of AMPARs
[[ [[ [[ [[ 4 [ 4 unknown [[
Desensitization and
deactivation rates
Y Y YY YY [ Y 4 [ desensitization
Y deactivation
unknown
mEPSC decay Y Y YY Y 4 unknown 4 no effect unknown
Resensitization no effect no effect [ [ no effect [ no effect unknown unknown
Mean channel
conductance
[ [ [ [ [ [ [ unknown unknown
Peak open probability 4 no effect no effect no effect Y no effect no effect unknown unknown
Intracellular
polyamine affinity
YY YY YY YY Y YY YY unknown unknown
Glutamate affinity [[ [[ [ [ Y no effect unknown [[ unknown
Kainate efficacy [[ [[ [[ [[ no effect [ no effect unknown unknown
CNQX efficacy [ [ [ [ unknown unknown 4 unknown unknown
Polyamine toxin
efficacy
[ [ [ [ unknown unknown unknown unknown unknown
Notation:[, increase;Y, decrease;4, variable effects/conflicting reports. Note: this chart represents our best approximation of data in the literature. Experimental caveats and conflicting results
are discussed in the text.
aHashimoto et al., 1999; Chen et al., 1999, 2000; Schnell et al., 2002; Tomita et al., 2003, 2005b; Yamazaki et al., 2004; Priel et al., 2005; Turetsky et al., 2005; Bedoukian et al., 2006;
Kott et al., 2007, 2009; Soto et al., 2007, 2009; Ko¨rber et al., 2007b; Milstein et al., 2007; Cho et al., 2007; Menuz et al., 2007; Suzuki et al., 2008; Jackson et al., 2011
b Tomita et al., 2003; Kott et al., 2007, 2009; Kato et al., 2007, 2010; Milstein et al., 2007; Cho et al., 2007; Menuz et al., 2007; Suzuki et al., 2008; Soto et al., 2009; Shi et al., 2009;
Jackson et al., 2011
c Tomita et al., 2003; Kott et al., 2007, 2009; Kato et al., 2007, 2010; Ko¨rber et al., 2007b; Milstein et al., 2007; Cho et al., 2007; Menuz et al., 2007; Suzuki et al., 2008; Soto et al., 2009; Shi et al.,
2009; Jackson et al., 2011
d Tomita et al., 2003; Rouach et al., 2005; Kott et al., 2007; Milstein et al., 2007; Cho et al., 2007; Menuz et al., 2007; Suzuki et al., 2008; Soto et al., 2009; Kott et al., 2009; Shi et al., 2009, 2010;
Kato et al., 2010; Jackson et al., 2011
e Tomita et al., 2003, 2005b; Kato et al., 2007, 2008, 2010; Soto et al., 2009
f Priel et al., 2005; Kato et al., 2007, 2008, 2010; Soto et al., 2009
g Schwenk et al., 2009; Shi et al., 2010; Kato et al., 2010
h von Engelhardt et al., 2010
i Kalashnikova et al., 2010
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Neuron
Reviewexpression of a stargazin construct with a phosphomimic
residue at this site greatly reduces AMPAR-mediated synaptic
transmission in hippocampal neurons (Choi et al., 2002; Chetko-
vich et al., 2002). Interestingly, activation of PKA with forskolin
fails to alter the synaptic localization of transfected stargazin
(Chetkovich et al., 2002), and forskolin actually increases
synaptic AMPAR currents (Carroll et al., 1998). The same threo-
nine residue is also phosphorylated through the mitogen-
activated protein kinase (MAPK) pathway. Paradoxically, phos-
phorylation of this site is associated with diametrically opposing
effects on synaptic AMPAR clustering and plasticity, depending
on the kinase that phosphorylates it (Stein and Chetkovich,
2010). Clearly, the physiological role of this phosphorylation
site remains to be determined.
The CTD of stargazin also has a series of nine conserved
serines common to all type I TARPs that, under basal conditions,
are the only detectable phosphorylated residues in cultured
cortical neurons (Tomita et al., 2005a). These serines, found
within a highly basic region of the CTD, are substrates for phos-
phorylation byCaMKII and/or PKC (Tomita et al., 2005a; Tsui and
Malenka, 2006). The physiological significance of this poly-
serine region of the CTD is suggested by evidence that induction
of NMDAR-dependent long-term depression (LTD) in the hippo-
campal CA1 region is dependent on dephosphorylation of star-
gazin through a protein phosphatase 1 (PP1) and PP2B-medi-
ated pathway. Expression of a phosphomimic stargazin
construct, in which all nine serines are phosphorylated,
enhances synaptic delivery of AMPARs (Tomita et al., 2005a;
Kessels et al., 2009) and prevents LTD. On the other hand,
expression of a phosphonull stargazin construct prevents the
induction of long-term potentiation (LTP) (Tomita et al., 2005a).
Additional evidence suggests that TARPs g-2 and g-8 are differ-
entially regulated by CaMKII and PKC (Inamura et al., 2006).
These findings demonstrate that TARPs are an important
target of CaMKII and PKC and may play a central role in the
bidirectional regulation of synaptic plasticity. How might the
phosphorylation state of TARPCTDs control AMPAR trafficking?
Conceivably, the basic residues within this region of the CTD
interact strongly with the acidic phosphate head groups of
surrounding membrane lipids, and this interaction is disrupted
by poly-serine phosphorylation. As a consequence, stargazin
would become more mobile for recruitment to the PSD. This
idea has been explored by generating knockin mice containing
either phosphomimic or phosphonull stargazin constructs. The
phosphomimic stargazin enhances cerebellar mossy fiber/
CGN AMPAR EPSCs, while the phosphonull construct reduces,
but does not eliminate, EPSCs (Sumioka et al., 2010). Thus, star-
gazin appears to interact with negatively charged lipid bilayers in
a phosphorylation-dependent manner, and this lipid interaction
inhibits the binding of stargazin to PSD-95. A similar mechanism
had been proposed for the PKCphosphorylation of theMARCKS
protein family (Arbuzova et al., 2002). These results suggest that
the regulation of the synaptic delivery of AMPARs is dependent
on the phosphorylation state of stargazin and its interaction
with membrane lipids. Additional work suggests that CaMKII
phosphorylation of stargazin CTDs promotes the trapping and
synaptic stabilization of laterally diffusing AMPARs (Opazo
et al., 2010), which may have important implications for the184 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.role of CaMKII in synaptic plasticity (Hayashi et al., 2000; Merrill
et al., 2005; Derkach et al., 2007).
Finally, through biochemical means, stargazin has been
shown to be S-nitrosylated at a cysteine residue in its CTD,
which results in an enhancement of GluA1 surface expression.
This represents a potential pathway through which nitric oxide
(NO) signaling could influence AMPAR trafficking (Selvakumar
et al., 2009).
TARP Modulation of AMPAR Gating and Pharmacology
On the basis of initial experiments in heterologous systems and
cerebellar CGNs, it was reasonable to imagine that the entirety of
stargazin’s role in AMPAR function was limited to that of a
receptor chaperone—trafficking receptors to the cell surface
and subsequently mediating their synaptic targeting, clustering,
and turnover. Later quantitative biochemical and biophysical
experiments made clear, however, that an increase in the cell
surface expression of AMPARs alone was insufficient to account
for the observed enhancement of steady-state agonist-evoked
currents (Yamazaki et al., 2004, Priel et al., 2005; Tomita et al.,
2005b). It was suggested, therefore, that stargazin, in addition
to its role in trafficking, could also be augmenting the functional
properties of AMPARs. Indeed, both type I and II TARPs modu-
late AMPAR gating and pharmacology to varying degrees in a
number of interrelated ways (Figure 3 and Table 1).
Gating Kinetics
In heterologous expression systems, coexpression of stargazin
with either GluA1 or GluA2 slows the rate of desensitization
and enhances the amplitude of steady-state currents in
response to glutamate, as compared with GluA1 or GluA2 alone.
In addition, coexpression with stargazin slows the rate of deac-
tivation and hastens recovery from desensitization (Priel et al.,
2005, Tomita et al., 2005b; Turetsky et al., 2005; Bedoukian
et al., 2006). These effects of stargazin on AMPAR kinetics could,
in part, be explained by the behavior of GluA4-mediated currents
at the single-channel level, which show that stargazin enhances
single-channel conductance and channel burst duration (Tomita
et al., 2005b). These molecular and biophysical studies demon-
strate that stargazin allosterically augments AMPAR currents
independent of its role in receptor trafficking. Furthermore, the
dual roles of stargazin could be ascribed to specific domains
of the stargazin protein and are functionally dissociable (Tomita
et al., 2005b). Subsequent work showed that TARPs not only
modulate the gating kinetics of AMPARs but do so in a TARP
subtype-dependent manner. The expression of different type I
TARPs along with AMPAR subunits in heterologous cells
results in differential effects on rise time, deactivation, and
desensitization kinetics. For example, g-4 and g-8 both slow
the deactivation of glutamate-evoked currents to a greater
extent than g-2 or g-3 (Milstein et al., 2007; Cho et al., 2007).
Differential effects of type I TARPs on the gating kinetics of heter-
ologously expressed AMPARs are also shown in other studies
(Kott et al., 2007; Ko¨rber et al., 2007b; Soto et al., 2007, 2009;
Suzuki et al., 2008). In addition, some TARPs confer a peculiar
component of desensitization kinetics referred to as ‘‘resensiti-
zation.’’ First observed with GluA1 coexpressed with g-7, resen-
sitization manifests as the slow increase in steady-state current
following rapid desensitization, in the sustained presence of
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Figure 3. TARP Modulation of AMPAR Gating and Pharmacology
Schematic summary of the myriad ways in which TARP association can
modulate the gating and pharmacology of AMPARs. Note that not every TARP
effect on AMPAR function is illustrated here. TARP modulation (red) is shown
relative to GluA alone (black). Represented are TARP-dependent changes in
deactivation and desensitization kinetics, as well as the phenomenon known
as resensitization. TARPs are known to modulate other channel properties
such as mean channel conductance, open probability, and intracellular poly-
amine affinity. TARPs also modulate AMPAR pharmacology in the form of
changes in glutamate affinity, kainate efficacy, CNQX efficacy, and sensitivity
to polyamine toxins such as philanthotoxin (PhTx). These functional properties
vary in a combinatorial manner depending on TARP subtype and AMPAR
subunit composition.
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Reviewagonist (Kato et al., 2007, 2008) (Figure 3). Subsequent work
showed that only TARPs g-4, g-7, and g-8 confer resensitization
kinetics (Kato et al., 2010). Although the physiological signifi-
cance of resensitization is unclear, determining its molecular
underpinnings would be of interest because it may inform the
structural basis of TARP subtype-dependent interactions with
AMPARs.
TARPs clearly modulate the kinetics of agonist-evoked
AMPAR currents in heterologous systems, but what are the
effects of TARPs on the kinetics of synaptic responses in
neurons? Viral infection of hippocampal slice cultures with a
chimeric construct designed to dissociate stargazin’s roles as
trafficking chaperone and allosteric modulator of gating show
that stargazin can modulate the amplitude and kinetics of native
AMPAR-mediated mEPSCs (Tomita et al., 2005b). Subse-
quently, TARP subtype-dependent effects observed in heterolo-
gous systems were largely mirrored in differential effects of
TARP expression on mEPSC amplitude, rise-time, and decay
in CGNs (Milstein et al., 2007; Cho et al., 2007). For example,
g-4 and g-8 slow the rise-time of mEPSCs to a greater extent
than g-2 or g-3, whereas g-4 slows the decay to a far greater
extent than g-2, g-3, or g-8 (Milstein et al., 2007). Domain swap-
ping experiments demonstrated that the TARP subtype-depen-
dent effects on gating kinetics could be largely attributed to
unique characteristics of the first extracellular domains (Milstein
et al., 2007; Cho et al., 2007). However, the TARP intracellular
domains (N-terminal, intracellular loop, and C-terminal) also
have unexpected roles to play in AMPAR gating kinetics (Milstein
andNicoll, 2009).What is the physiological significance of TARP-
dependent modulation of deactivation and desensitization
kinetics? Clearly the most straightforward effect would be an
enhancement in charge transfer associated with synaptic gluta-
mate release, which, when combined with other important vari-
ables that determine the kinetics of AMPAR-mediated synaptic
currents (Jonas and Spruston, 1994; Edmonds et al., 1995; Conti
and Weinberg, 1999; Jonas, 2000), would be predicted to have
important functional ramifications on dendritic integration,
calcium entry, coincidence detection, and spike-timing-depen-
dent plasticity.
Channel Pharmacology
The presence of stargazin potentiates the affinity of AMPARs to
glutamate, evidenced by the leftward shift in the glutamate dose-
response curve (Yamazaki et al., 2004; Tomita et al., 2005b, Priel
et al., 2005; Turetsky et al., 2005). However, the degree of
enhancement of glutamate affinity by the type I TARPs depends
on GluA subunit composition, GluA splice variant (flip versus
flop), and TARP subtype (Kott et al., 2007, 2009; Tomita et al.,
2007a, 2007b). Interestingly, AMPARs exhibit a bell-shaped
glutamate concentration-response curve when steady-state
instead of peak current is measured in some neuronal
preparations, a phenomenon referred to as autoinactivation (Vla-
chova´ et al., 1987; Raman and Trussell, 1992; Kinney et al., 1997)
(Figure 3). Recent work suggests that autoinactivation may be
explained by the rapid dissociation of TARPs from AMPARs at
glutamate concentrations above 10 mM (Morimoto-Tomita
et al., 2009).
KA is a glutamate analog that acts as a partial agonist of
AMPARs, meaning that even at saturating concentrations, itNeuron 70, April 28, 2011 ª2011 Elsevier Inc. 185
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Reviewonly induces submaximal channel activation in the form of small,
nondesensitizing current (Zorumski and Yang, 1988; Patneau
and Mayer, 1991). The structural basis for partial agonist action
lies in its failure to induce complete cleft closure of the AMPAR
ligand-binding core (Jin et al., 2003). The presence of TARPs
greatly enhances KA efficacy to the point that it behaves as
a full agonist in both heterologous cells and neurons (Tomita
et al., 2005b; Turetsky et al., 2005) (Figure 3 and Table 1). The
ratio of KA-evoked current and glutamate-evoked current, or
KA/Glu ratio, has since been shown to be an invaluable tool in
determining the presence or absence of TARPs and in estimating
AMPAR-TARP stoichiometry (Shi et al., 2009).
Derivatives of quinoxaline such as 6-cyano-7-nitroquinoxa-
line-2,3-dione (CNQX) have been commonly used as competitive
antagonists of AMPARs. Paradoxically, CNQX enhances the
excitability of some cell types (Maccaferri and Dingledine,
2002; Menuz et al., 2007). Furthermore, bath application of
CNQX can induce a steady-state inward current in neurons
that can be enhanced by allosteric AMPAR potentiators such
as tichloromethiazide (TCM) and blocked by selective, noncom-
petitive AMPAR antagonists such as GYKI53655. These data
suggest that in neurons, CNQX behaves as a partial agonist of
AMPARs. Using heterologous cells with AMPARs coexpressed
with any one of the type I TARPs, it was revealed that CNQX
can only behave as a partial agonist when AMPARs are TARP-
associated (Menuz et al., 2007). Furthermore, TARP subtypes
can differentially affect CNQX efficacy (Kott et al., 2009) (Figure 3
and Table 1). This effect of TARPs is generally consistent with the
notion that TARPs influence the degree to which ligand binding
translates into cleft closure and channel opening, possibly
through a direct interaction with the linker domains (Milstein
and Nicoll, 2008).
TARP association also modulates the action of so-called allo-
steric AMPAR potentiators, like the commonly used compound
cyclothiazide (CTZ), which blocks desensitization in a splice-
variant-dependent manner (Partin et al., 1994) by acting at the
AMPAR dimer interface (Sun et al., 2002). Consistent with the
role of TARPs in generally enhancing AMPAR function, stargazin
association boosts AMPAR affinity for AMPAR potentiators while
modulating their splice variant specificity (Tomita et al., 2006).
TARPs also modulate the affinity of negative allosteric AMPAR
modulators like GYKI53655 (Cokic and Stein, 2008; Schober
et al., 2011).
Pore Properties
TARPs have effects on AMPAR pore properties that are likely
secondary to direct modulation of the ligand-binding core and/
or linker domains. Single-channel analysis has shown that indi-
vidual AMPARs can traverse any of several distinct subconduc-
tance states (Jahr and Stevens, 1987; Cull-Candy and Usowicz,
1987; Ascher and Nowak, 1988). Single-channel recordings from
heterologously expressed GluA2-lacking AMPARs show that
the presence of stargazin favors the probability of channels
occupying the highest of these subconductance states and
enhancing channel burst-duration during prolonged agonist
application (Tomita et al., 2005b). Furthermore, ultrafast agonist
application and subsequent nonstationary fluctuation analysis
(NSFA) has been a valuable means of determining that TARP
association dramatically enhances AMPAR mean channel186 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.conductance with variable effects on peak open probability
(Figure 3 and Table 1). Thus far, TARPs have not exhibited any
subtype-dependent differences in the enhancement of mean
channel conductance of GluA2-lacking AMPARs (Soto et al.,
2007, 2009; Suzuki et al., 2008). However, recent evidence
shows that TARP subtypes can differentially modulate the
mean channel conductance of heteromeric, GluA2-containing
AMPARs (Jackson et al., 2011). Even the type II TARP g-5
enhances the mean channel conductance of both homomeric
and heteromeric AMPARs (Soto et al., 2009).
GluA2-lacking, calcium-permeable AMPARs are subject to
voltage-dependent block by endogenous intracellular poly-
amines such as spermine and spermidine, resulting in character-
istic inwardly rectifyingcurrent-voltage (I-V) relationships (McBain
and Dingledine, 1993; Bochet et al., 1994; Jonas et al., 1994;
Geiger et al., 1995; Kamboj et al., 1995; Koh et al., 1995; Bowie
and Mayer, 1995). The degree of rectification of both synaptic
and agonist-evoked AMPAR-mediated current is frequently
usedasametric forGluA2content (Isaacet al., 2007). TARPasso-
ciation dramatically diminishes the affinity of the AMPAR pore for
intracellular spermine, thus enhancing charge transfer and
calcium entry (Bowie and Mayer, 1995; Soto et al., 2007; 2009)
(Figure 3 and Table 1). TARP-dependent effects on I-V shape
may account for rectification being a misleading measure of
synaptic and extrasynaptic GluA2 content (Jackson and Nicoll,
2011). Moreover, recent evidence suggests that TARP associa-
tion enhances the efficacy of externally applied polyamine toxins
such as philanthotoxins (PhTx) in a subunit-dependent and
agonist-dependent manner (Jackson et al., 2011).
Modulation of AMPAR Gating by Type II TARPs
The effects of the type II TARPs on AMPAR gating are complex
and sometimes contradictory. TARP g-7, but not g-5, was shown
to display modest slowing of both the deactivation and desensi-
tization kinetics of GluA1 homomers (Kato et al., 2007), although
in another study neither g-7 nor g-5 had any effect on the desen-
sitization kinetics of GluA4 homomers, but had differential effects
on other gating parameters (Soto et al., 2009). Andwhileg-5 does
nothing to unedited GluA subunits, Kato and coworkers showed
that it can modulate the gating of edited GluA2(R)-containing,
calcium-impermeable AMPARs, seeming to have a more
pronounced effect on GluA2/3 heteromers than GluA1/2 hetero-
mers, by accelerating both deactivation and desensitization.
Furthermore, g-5 association lowers the affinity of GluA2-con-
taining AMPARs for glutamate (Kato et al., 2008). TARP g-5,
therefore, appears to be a contrarian TARP that does not partic-
ipate in AMPAR trafficking but modulates AMPARs of a specific
composition, in a way that is opposite to that of other TARPs.
The eccentric functional behavior of g-5 is all the more remark-
able when compared with that of g-7, with which it exhibits
a high degree of sequence homology. A subsequent study from
Soto and coworkers showed that g-5 indeed exhibits irregular
behavior, but in an entirely different way than that described by
Kato et al. (2008). Both g-7 and g-5 enhance the mean channel
conductance and have a modest effect on the rectification of
Glu4 homomers. In striking contrast to Kato et al. (2008), g-5
was found to preferentially modulate the mean channel conduc-
tance of AMPARs composed of ‘‘long-form’’ subunits, which are
Neuron
Reviewpredominantly GluA2 lacking and calcium permeable (Soto et al.,
2009) (Table 1). Further study will be required to reconcile these
contradictory findings. Nevertheless, the unique characteristics
of type II TARPs addadegree of functional diversity, andpossibly
bidirectional control, to AMPAR trafficking and gating.
TARP Mutant Mice and the Role of TARP Subtypes
in Specific Brain Regions
TARPs exhibit widespread and extensively overlapping expres-
sion patterns throughout the brain as assessed by in situ hybrid-
ization. Type I and II TARPsare found inboth neuronsandglia and
display complex, cell-type-specific expression that varies over
the course of development (Tomita et al., 2003; Fukaya et al.,
2005; Lein et al., 2007). Given their apparent functional redun-
dancy, why are there so many TARP family members? Why do
some cell types appear to only express one TARP subtype while
another expressesamultitude?Agreatdeal canbe learnedabout
the subtype-specific role of TARPs in brain function by examining
their differential expression patterns and complex effects on
AMPAR trafficking and gating following their genetic deletion.
A useful way of unpacking these questions is to consider TARP
subtype-specific effects in well-characterized cell types in the
hippocampus, cerebellum, neocortex, and thalamus (Table 2).
Hippocampus
Because the expression of synaptic plasticity at Schaffer colat-
eral-CA1 pyramidal neuron synapses depends on the activity-
dependent regulation of postsynaptic AMPARs (Malenka and
Bear, 2004; Kerchner and Nicoll, 2008), a compelling issue since
the discovery of TARPs has been discerning their role in modu-
lating AMPAR trafficking and plasticity in these neurons. CA1
pyramidal neurons are known to express multiple TARP family
members, including stargazin, g-3, g-4, g7, and g-8. However,
a striking and unique feature of the hippocampus is the selective
enrichment of g-8 (Tomita et al., 2003; Fukaya et al., 2005; Lein
et al., 2007). The generation of the g-8 knockout (KO) mouse re-
vealed that AMPAR expression and distribution are selectively
diminished in the hippocampus, as evidenced by the dramatic
reduction in hippocampal GluA subunit protein expression
without a corresponding change in amounts of mRNA. At the
subcellular level, immunogold electron microscopy showed
that both synaptic and extrasynaptic AMPARs are severely
diminished. Interestingly, CA1 pyramidal neurons from g-8 KO
mice exhibit relatively modest reductions in field EPSC (fEPSC)
slope, AMPA/NMDA ratio, and mEPSC amplitude, but do exhibit
the near-complete loss of extrasynaptic AMPARs. The impact of
this pattern of AMPAR deficit on hippocampal synaptic plasticity
is impairment in LTP without a significant effect on LTD (Rouach
et al., 2005). In contrast to the role of stargazin inCGNs,where the
absenceof functional stargazin results in the lossof both synaptic
and extrasynaptic AMPARs, g-8 seems to have a specialized role
in delivering AMPARs to extrasynaptic sites in hippocampal
neurons.Whether or not the impairment in LTP is the direct result
of losing g-8, or whether it is secondary to the loss of the extrasy-
naptic pool of AMPARs, remains to be determined. The impact of
losing g-8 is likelymitigated by the presence of other TARP family
members in CA1 pyramidal neurons. Initial experiments using
stargazer/g-8 double KOmice suggested that AMPAR-mediated
transmission inCA1pyramidal neurons is further reduced, but noteliminated (Rouach et al., 2005). Additional biochemical and
anatomical evidence suggests that g-8 and stargazin may be
present in separate but overlapping subcellular compartments
in hippocampal neurons (Inamura et al., 2006). Stargazer (Hashi-
moto et al., 1999), stargazer/g-3 double KO (Menuz et al., 2008),
and g-3/g-4 double KOmice (Menuz et al., 2009) all fail to exhibit
any significant impairment in synaptic transmission in CA1 pyra-
midal neurons. Only g-3/g-4/g-8 triple KOmice display defects in
synaptic transmission that are similar to the loss of g-8 by itself. It
is enticing to speculate that in a stargazer/g-3/g-4/g-8 quadruple
KO pyramidal neuron, AMPAR-mediated transmission would be
entirely eradicated, but so far this goal has remained out of reach,
owing to some KO combinations being embryonically lethal (Me-
nuz et al., 2009) (Table 2). Single-cell deletion strategieswould be
required for future investigation. Taken together, these data
suggest that at least in CA1 pyramidal neurons, multiple type I
TARPs are largely redundant and that any one TARP, to varying
degrees, can compensate for the loss of the others in mediating
AMPAR synaptic targeting. However, g-8 appears to have
a unique role in regulating the pool of extrasynaptic AMPARs.
In addition, the stoichiometry of AMPAR-TARP g-8 interactions,
as measured by the KA/Glu ratio, appears to vary between
distinct cell types within the hippocampus (Shi et al., 2009).
Another striking TARP expression pattern in the hippocampus
is the robust expression of g-5 in the CA2 region (Fukaya et al.,
2005; Lein et al., 2007). Consistent with the contrarian nature
of g-5, glutamate-evoked currents from acutely dissociated
CA2 pyramidal neurons exhibit faster desensitization kinetics
and smaller steady-state currents than those from CA3 (Kato
et al., 2008). Curiously, g-8 is also robustly expressed in CA2,
as it is throughout the hippocampus (Fukaya et al., 2005; Lein
et al., 2007), yet the channel kinetics appear to be more in line
with those of g-5 than g-8. Do g-5 and g-8 compete for control
of AMPAR gating? Are g-5-associated AMPARs concentrated
at the soma while g-8-associated AMPARs are at synapses?
Further work is required to answer these intriguing questions.
Finally, the function of theCA2 region itself has been a longstand-
ing mystery; however, recent characterization of the unique role
that CA2 pyramidal neurons play within the hippocampal micro-
circuit (Chevaleyre and Siegelbaum, 2010) may point the way for
a physiological role for g-5 in hippocampal function.
Cerebellum
The cerebellum is another powerful model system for studying
glutamatergic transmission and synaptic plasticity (Hansel
et al., 2001; Ito, 2006), and is another brain region where TARP
KO mice have shed light on the role of TARP subtype-specific
AMPAR trafficking and gating (Coombs and Cull-Candy, 2009).
CGNs from stargazer mice are virtually devoid of both synaptic
and extrasynaptic AMPARs (Hashimoto et al., 1999; Chen
et al., 2000), suggesting that stargazin accounts for the entirety
of type I TARP function in this cell type. This is somewhat
surprising given the central importance of TARPs in AMPAR
function and that most cell types examined thus far express
multiple, largely redundant TARP subtypes.
Interestingly, AMPAR-mediated synaptic transmission in cere-
bellar Golgi cells (GoCs), which reside in the granule cell layer
and appear to be unique in the cerebellum in robustly expressing
TARP g-3 in addition to stargazin (Fukaya et al., 2005; Lein et al.,Neuron 70, April 28, 2011 ª2011 Elsevier Inc. 187
Table 2. Summary of Behavioral and AMPAR Trafficking Phenotypes Observed in TARP Mutant Mice
Mutant
Mouse Targeting
Viability/
Survival Behavioral Phenotype
Cell-Type Specific AMPAR
Trafficking Phenotype
stargazer (g-2)a spont viable dyskinesia, head-tossing,
severe ataxia,
spike-wave discharges
(seizures), low body weight
CGN: severe loss of synaptic and
extrasynaptic AMPARs; PC: reduction
in CF and PF synaptic AMPARs with no loss
of extrasynaptic AMPARs; SC: severe
reduction in PF synaptic AMPARs,
with no loss of extrasynaptic AMPARs;
CA1: normal; nRT: reduction in
synaptic AMPARs; TRN: normal
g-3b KO viable normal GoC: normal; CA1: normal
g-4c KO viable normal MSN: loss of synaptic AMPARs in
neonates (P5–6), normal in juveniles
(P14–16)
g-7d flox
(global)
viable normal PC: normal
g-8e KO viable normal CA1: modest reduction in synaptic
AMPARs but severe loss of
extrasynaptic AMPARs
g-2/g-3f spont/KO failure
to thrive
more severe ataxic phenotype
than stg, low bodyweight
GoC: reduction in PF synaptic
AMPARs; CA1: normal
g-2/g-4g spont/KO failure to
thrive/viable
(see references)
enhancement in seizures
in waggler and stargazer3J
mutants
N/A
g-2/g-7d flox/flox
(global)
viable more severe ataxic phenotype
than stg, low bodyweight
PC: severe loss of CF synaptic
AMPARs
g-2/g-8h spont/KO failure to thrive CA1: more severe reduction in
synaptic AMPARs than g-8 KO alone
g-3/g-4i KO/KO viable normal CA1: normal
g-2/g-3/g-4i spont/KO
/KO
lethal newborns do not breathe
or move
CTX: normal synaptic and extrasynaptic
AMPARs in cultured embryonic neurons;
SpC: normal synaptic and extrasynaptic
AMPARs in embryonic slices
g-2/g-3/g-8i spont/KO
/KO
lethal N/A N/A
g-3/g-4/g-8i spont/KO
/KO
viable normal CA1: modest reduction in synaptic
AMPARs, similar to loss of g-8 alone
Abbreviations: spont, spontaneousmutation; KO, knockout; flox, conditional knockout; CGN, cerebellar granule neurons; PC, cerebellar Purkinje cells;
SC, cerebellar stellate cells; GoC, cerebellar Golgi cells; CF, cerebellar climbing-fiber pathway; PF, cerebellar parallel-fiber pathway; CA1,
hippocampal CA1 pyramidal neurons; nRT, thalamic nucleus reticularis neurons; TRN, thalamic relay neurons; MSN, striatal medium spiny neurons;
CTX, cortical neurons; SpC, spinal cord neurons.
a Noebels et al., 1990; Letts et al., 1998; Hashimoto et al., 1999; Chen et al., 1999, 2000; Menuz et al., 2008; Menuz and Nicoll, 2008, Jackson
and Nicoll, 2011
bMenuz et al., 2008
c Letts et al., 2005, Milstein et al., 2007
dYamazaki et al., 2010
eRouach et al., 2005
fMenuz et al., 2008, 2009
g Letts et al., 2005, Menuz et al., 2009
hRouach et al., 2005; Menuz et al., 2009
iMenuz et al., 2009
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Review2007), is unaffected in stargazer mice. Likewise, GoCs from g-3
KOmice are indistinguishable from those of wild-type. However,
GoCs in the stargazer/g-3 double KO mouse exhibit severe
defects in AMPAR-mediated synaptic transmission. Consistent
with the notion that type I TARPs are largely redundant in many188 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.cell types, stargazin and g-3 are capable of compensating for
the loss of the other. Another interesting observation in this study
is that GoC synaptic AMPARs, which have linear I-Vs in wild-type
mice, are moderately rectifying in the stargazer/g-3 double KO
mouse, implicating TARPs in determining subunit composition.
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tently fail to thrive, and exhibit ataxia that ismore severe than that
in stargazer mice (Menuz et al., 2008).
Cerebellar Purkinje cells (PCs) are the primary output of the
cerebellar cortex and are innervated by both CGNs in the form
of parallel fibers and brainstem neurons in the form of powerful
climbing fiber inputs. PCs are a useful illustration of a cell type
that clearly expresses one type I TARP, stargazin, and one
type II TARP, g-7 (Fukaya et al., 2005; Lein et al., 2007). PCs
from stargazer mice exhibit reductions in both parallel fiber
(70% loss) and climbing fiber (50% loss) -evoked synaptic
transmission, which likely contributes to stargazer’s prominent
ataxia. Interestingly, stargazer PCs do not exhibit any defect in
agonist-evoked currents from outside-out patches (Menuz and
Nicoll, 2008). If stargazin is indeed the only type I TARP ex-
pressed in PCs, this suggests that in its absence, either g-7
can compensate for a portion of the synaptic targeting and the
entirety of the extrasynaptic trafficking, or that there are TARP-
independent trafficking mechanisms at play. The recent genera-
tion of a conditional KO mouse in which both stargazin and g-7
are deleted shows that the additional removal of g-7 further
reduces PC climbing fiber responses to 10% of wild-type,
thus implicating g-7 in mediating some synaptic targeting in
the absence of stargazin. Phenotypically, the stargazin/g-7
double KO appears to exhibit more severe ataxia than stargazin
KOs (Yamazaki et al., 2010). The impact that these various TARP
deletions may have on forms of cerebellar synaptic plasticity,
such as LTD at parallel fiber-PC synapses, remains to be seen.
Cerebellar stellate cells (SCs) and basket cells (BCs) are small
interneurons that reside in the molecular layer, receive parallel
fiber input, and mediate feedforward inhibition onto PCs. Recent
work has shown that SCs from stargazermice exhibit a profound
loss in synaptic AMPARs but preservation of extrasynaptic
receptors (Jackson and Nicoll, 2011), underscoring a possible
role for different TARP family members in the subcellular
compartmentalization of AMPARs in neurons (Rouach et al.,
2005; Inamura et al., 2006; Menuz and Nicoll, 2008; Ferrario
et al., 2011). In addition, parallel fiber-SC synapses exhibit a
unique form of synaptic plasticity (Liu and Cull-Candy, 2000)
that is compromised in stargazermice (Jackson andNicoll, 2011).
Thus far, Bergmann glial cells (BGCs) are the only glial cells
that have been studied in any detail in the context of TARPs.
BGCs are essential for the development and function of the
cerebellar cortex (Bellamy, 2006) and expression of calcium-
permeable AMPARs (Iino et al., 2001). Interestingly, BGCs
express both TARP g-4 and TARP g-5 (Tomita et al., 2003; Fu-
kaya et al., 2005; Lein et al., 2007). Although g-4 is the predom-
inant TARP expressed in the brain during development, its
expression persists in adult BGCs (Tomita et al., 2003). BGCs
have been used as a model system for examining AMPAR
subunit-specific trafficking and gating by g-5. The AMPAR prop-
erties of BGCs closely match those of heterologous cells in
which GluA4 is coexpressed with g-5, suggesting that g-5 has
a functional role in modulating glutamatergic transmission in
BGCs (Soto et al., 2009).
Neocortex and Thalamus
In addition to profound ataxia and dyskinesia, stargazer mice
exhibit seizure activity characterized by SWDs, qualitativelysimilar to human absence epilepsy (Noebels et al., 1990). To
investigate the cellular mechanisms that account for this aspect
of the stargazer phenotype, several studies have focused on the
neocortex and thalamus. Dysregulation of excitability and
synchrony within recurrent corticothalamic loops has been
implicated in the origin of absence seizures (Huguenard and
McCormick, 2007; Beenhakker and Huguenard, 2009). In early
characterizations of stargazermice, defects in neocortical excit-
ability were thought to account for the occurrence of seizures
and frequent SWDs. Specifically, layer V pyramidal neurons
from stargazermice are hyperexcitable, and exhibit spontaneous
giant depolarizing EPSPs, a reduction in the postburst afterhy-
perpolarization, and an enhancement in the hyperpolarization-
activated cation current, or Ih (Noebels et al., 1990; Di Pasquale
et al., 1997). Interestingly, stargazer/g-3/g-4 triple KO mice,
despite not surviving past birth, do not exhibit any defect in
AMPAR-mediated transmission in late embryonic neocortical
neurons (Menuz et al., 2009).
Subsequent work on TARPmutants focused on neurons in the
thalamus, in particular the activity of thalamic nucleus reticularis
(nRT) neurons and thalamocortical relay neurons (TRNs), which
have pivotal roles to play in the generation of absence seizures
(Huguenard andMcCormick, 2007; Beenhakker andHuguenard,
2009; Chetkovich, 2009). Menuz and coworkers found that
glutamatergic synapses onto inhibitory nRT neurons, but not
onto excitatory TRNs, were disrupted in stargazer mice. These
data suggest that disinhibition in the thalamus may contribute
to seizure activity, characteristic of the stargazer mouse (Menuz
and Nicoll, 2008). In addition, CNQX and the related quinoxaline-
derived compound DNQX, but not NBQX, selectively depolarize
nRT neurons, but not TRNs (Lee et al., 2010), pointing to possible
cell-type-specific differences in TARP expression or function
within the thalamus. Finally, TARP g-4 has also been shown to
have a role to play in the generation of SWDs and absence
seizures when crossed with hypomorphic stargazer alleles
such as waggler and stargazer3J (Letts et al., 2005). Future
work will be required in order to dissect the functional roles
of various TARP family members in regulating glutamatergic
transmission, and ultimately, the balance of excitation and inhi-
bition between specific cell types within corticothalamic
networks.
TARPs and Human Disease
Defects in glutamatergic synaptic transmission have been impli-
cated in the pathogenesis of numerous neurodegenerative
and psychiatric diseases. Emerging human genetic evidence
suggests that TARPs may play a role in the etiology of disorders
as diverse as epilepsy, schizophrenia, and neuropathic pain.
Homozygosity analysis of a consanguineous family exhibiting a
high frequency of epilepsy, schizophrenia, and/or hearing loss
revealed a link to a region of chromosome 22 that includes the
human stargazin gene (CACNG2) (Knight et al., 2008). The
human g-3 gene (CACNG3) on chromosome 16 has been impli-
cated as a susceptibility locus in a subpopulation of patients
suffering from childhood absence epilepsy (CAE) (Everett
et al., 2007), whereas another study of consanguineous families
showed that CACNG2 is not linked with CAE (Abouda et al.,
2010). In a genetic study of families with a high incidence ofNeuron 70, April 28, 2011 ª2011 Elsevier Inc. 189
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ulation of patients (Liu et al., 2008). Furthermore, postmortem
analyses of gene expression in the dorsolateral prefrontal
cortices of patients with schizophrenia, bipolar disorder, and
major depression revealed aberrant expression of stargazin
(Beneyto and Meador-Woodruff, 2006; Silberberg et al., 2008).
Interestingly, certain stargazin polymorphisms were shown to
be associated with enhanced responsiveness to lithium, a
common treatment for bipolar disorder (Silberberg et al.,
2008). Finally, polymorphisms in human stargazin have been
linked to susceptibility to chronic pain in a subset of cancer
patients (Nissenbaum et al., 2010). These human genetic and
histological data are complex, and in some cases contradictory,
but when taken together, point to a plausible link between
TARPs and the pathophysiology of several neurological and
psychiatric disorders. TARPs may therefore serve as novel
pharmacological targets and/or markers for a variety of human
diseases.
TARPs and iGluR Trafficking and Gating in C. elegans
As the role of TARPs in mammalian systems was being worked
out, Maricq and colleagues identified an unrelated auxiliary
subunit for GLR-1, the AMPAR homolog in C. elegans, using
an elegant genetic screen (Zheng et al., 2004). In brief, they
made a transgenic worm expressing a GLR-1 subunit containing
the same mutation that occurs in lurcher mutant mice. This
results in a constitutively active GLR-1, a gain-of-function
mutation that causes a marked ‘‘hyper-reversal’’ movement
phenotype. They then screened for mutations that suppressed
this behavior and identified suppressor of lurcher (sol-1).
SOL-1 is predicted to be a type 1 transmembrane protein with a
single transmembrane domain and four extracellular N-terminal
complement subcomponents (C1r/C1s), urchin embryonic
growth factor (Uegf), and bone morphogenetic protein (Bmp1),
comprising CUB (C1r/C1s/Uegf/Bmp1) domains (Figures 2B
and 2C). CUB domains are conserved, developmentally regu-
lated, structural modules present in the extracellular domains
of a diverse set of membrane proteins (Bork and Beckmann,
1993). SOL-1 colocalizes with GLR-1 at synaptic puncta, but is
not necessary for the surface expression of GLR-1. Coimmuno-
precipitation studies in COS-7 cells show that antibodies to SOL-
1 coprecipitate GLR-1. Despite the seemingly normal synaptic
targeting of GLR-1 in the absence of SOL-1, electrophysiological
recordings from neurons expressing GLR-1 demonstrate that
SOL-1 is essential for GLR-1 function. On the other hand,
NMDAR function remains intact. Further studies indicate that
SOL-1 controls the gating of GLR-1 and that the extracellular
CUB domain 3 is required for this action (Zheng et al., 2006).
Interestingly, and in striking contrast to vertebrate AMPARs,
expression of GLR-1 in heterologous cells fails to elicit currents,
indicating that a functional GLR-1 requires one or more addi-
tional proteins. Surprisingly, expression of SOL-1 together with
GLR-1 in heterologous cells also fails to restore GLR-1 function.
However, expression of a GLR-1 variant with mutations that
greatly enhance gating, but is incapable of generating gluta-
mate-evoked responses on its own, can generate substantial
current in the presence of SOL-1. This indicates that GLR-1 is
on the surface and that SOL-1 can interact with GLR-1.190 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.What additional protein or proteins are required for GLR-1
function? This could be another unidentified GLR subunit or an
additional auxiliary protein. Based on weak sequence identity
to vertebrate stargazin (25%), a C. elegans stargazin-like
protein was identified (Ce STG-1) (Walker et al., 2006a). Expres-
sion of STG-1 together with GLR-1 and SOL-1 reconstitutes
glutamate-evoked currents from GLR-1 in Xenopus oocytes.
Although expression of GLR-1 and STG-1 produces little current
in response to bath-applied glutamate in oocytes, ultrafast appli-
cation of glutamate indicates that, in the presence of STG-1,
GLR-1 produces currents that rapidly and completely desensi-
tize in several milliseconds (Walker et al., 2006b). Thus, SOL-1
is actually not required for the gating of GLR-1; rather, SOL-1
modulates GLR-1 function by greatly slowing its desensitization
and enhancing steady-state currents. Is STG-1 necessary for
GLR-1 function in C. elegans neurons? To answer this question
STG-1 was deleted from C. elegans, but GLR-1 function re-
mained intact (Wang et al., 2008). Based on the possibility that
another STG-1-like protein might exist and mask the loss of
STG-1, this mutant was crossed toworms expressing the lurcher
mutant and the progeny was screened for mutants that could
suppress the abnormal behavior. Wang et al. identified STG-2
and found that a worm lacking both STG-1 and STG-2 is entirely
devoid of GLR-1 function, despite the normal surface/synaptic
trafficking of GLR-1. Why is it that GLR-1 requires STGs for func-
tion while vertebrate AMPARs are functional on their own in
heterologous expression systems? One possibility, given the
low amino acid identity among STG-1, STG-2, and stargazin, is
that additional TARPs with more limited identity might exist.
Alternatively the heterologous systems used to study AMPARs
might have endogenous TARPs given the surprising finding
that Xenopus oocytes endogenously express numerous iGluR
subunits (Schmidt et al., 2009). Also, CNS neurons other than
CGNs are likely to express other TARPs, which could account
for the inability of Menuz et al. (2009) to silence AMPAR function
with multiple TARP KOs. Interestingly, GluA1 expressed in
C. elegans muscles, which lack glutamate receptors, is unre-
sponsive to glutamate, but coexpression of vertebrate stargazin
rescues function (Wang et al., 2008).
Taken together these findings indicate that GLR-1 in
C. elegans requires, in addition to the pore-forming subunit,
two distinct auxiliary subunits for normal function. The finding
that auxiliary subunits are essential for the function of the pore-
forming subunits of either ligand- or voltage-gated channels is
unprecedented. It is of interest that while the effects of stargazin
on AMPAR gating have largely been preserved throughout
evolution, stargazin has acquired an additional critical role as
a chaperone for the trafficking of AMPARs to the surface and
to synapses in vertebrates. The sequence of GLR-1 is only
slightly more similar to vertebrate AMPARs than to vertebrate
KARs. However, the ability of vertebrate and invertebrate TARPs
to function interchangeably with the two receptors indicates that
GLR-1 is, in fact, functionally an AMPAR.
Transmembrane AMPAR Auxiliary Subunits
beyond TARPs
TARPs appear to be associated with most neuronal AMPARs
(Tomita et al., 2003, Menuz et al., 2007). However, recent
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addition to TARPs, unrelated transmembrane proteins that
exhibit similar effects on AMPAR trafficking and/or gating, and
are therefore candidate auxiliary subunits. These exciting recent
findings provide us with a bewildering and daunting level of
combinatorial possibilities when we consider how this host of
proteins may interact with AMPARs and with each other.
Cornichon Homologs-2 and -3
Recent proteomic analyses identified transmembrane proteins
Cornichon homologs-2 and -3 (CNIH-2 and CNIH-3) as binding
to AMPARs (Schwenk et al., 2009). CNIHs are highly conserved
evolutionarily with Cornichon (Cni) and Erv14p, the Drosophila
and yeast homologs, respectively, serving as chaperones that
aid in the forward trafficking of epidermal growth factor
receptor (EGFR) ligands from the ER to the Golgi (Roth et al.,
1995; Powers and Barlowe, 1998; Hwang et al., 1999; Bo¨kel
et al., 2006; Castro et al., 2007; Hoshino et al., 2007). Using
antibody shift assays with solubilized membrane fractions
from whole rat brain, Schwenk and coworkers report the
surprising finding that AMPARs associate primarily with CNIHs
and that AMPARs associated with TARPs represent a smaller
and largely nonoverlapping population. When expressed in
heterologous cells, CNIHs were found to enhance AMPAR
surface expression and slow the deactivation and desensitiza-
tion kinetics of agonist-evoked currents to an even greater
extent than stargazin (Schwenk et al., 2009; Tigaret and Cho-
quet, 2009; Jackson and Nicoll, 2009; Brockie and Maricq,
2010). Further studies, mostly focusing on CNIH-2, have found
that CNIHs and TARPs share a number of other properties.
They both can immunoprecipitate GluA1, although considerably
more GluA1 is pulled down with TARPs. In addition, they both
promote the forward trafficking of GluA1 in the ER as measured
by the glycosylation state of the receptor. Expression of
a GluA1 construct that is covalently linked to g-8 generates
an AMPAR associated with the full complement of four g-8
molecules where overexpression of g-8 causes no further slow-
ing of deactivation. However, expression of CNIH-2 does cause
further slowing, strongly suggesting the presence of two
nonoverlapping binding sites for these two proteins. CNIH-2
increases the mean channel conductance with no change in
the channel open probability, similar to TARPs. However, in
contrast to TARPs, CNIH-2 only has a modest effect on the
efficacy of AMPARs to the partial agonist KA. Furthermore,
CNIH-2 and –3 decrease spermine affinity for GluA2-lacking
receptors, similar to the effect of stargazin (Shi et al., 2010).
Finally, CNIH-2 has an antagonistic effect on TARP-dependent
resensitization. As described previously, when GluA subunits
are expressed with g-4, g-7, or g-8, glutamate-evoked currents
slowly recover in the continued presence of glutamate with a
time constant of about 3 s. This phenomenon is not seen with
GluA1 alone or coexpressed with stargazin, g-3, or g-5. Inter-
estingly, coexpression of CNIH-2 prevents this resensitization
(Kato et al., 2010).
What role might CNIHs play in neurons? Stargazer CGNs
provide an ideal preparation for addressing this question
because they express little CNIH-2 and surface AMPARs are
essentially absent in the stargazer mouse. Expression of
CNIH-2 fails to rescue synaptic currents in CGNs, although itis able to rescue a small component of glutamate-evoked
whole-cell currents. The decay time constant of synaptic
currents, as well as glutamate-evoked currents from nucleated
patches, in CGNs from the stargazer heterozygote, which has
reduced AMPAR/g-2 stoichiometry, is also unaltered by the
expression of CNIH-2. These results suggest that CNIH-2 is
not associated with surface AMPARs even when overexpressed
(Shi et al., 2010). In contrast, another study reported that CNIH-2
can indeed slow the synaptic currents rescued by g-8 in
stargazer CGNs (Kato et al., 2010). There is also some disagree-
ment concerning the cellular distribution of CNIH-2. Shi and
coworkers found that although CNIH-2 could be detected on
the surface of HEK293 cells, it is undetectable on the surface
of hippocampal neurons. Furthermore, immunocytochemical
experiments found that FLAG-tagged CNIH-2 largely colocalizes
with the cis-Golgi marker GM130 in both hippocampal neurons
and CGNs (Shi et al., 2010). In contrast, Kato and coworkers
found that CNIH-2 could not only be detected on the surface
of hippocampal neurons, but also colocalizes with both GluA1
and TARPs (Kato et al., 2010). Expression of CNIH-2 in hippo-
campal pyramidal neurons fails to slow the deactivation or
desensitization kinetics of glutamate responses from outside-
out patches (Shi et al., 2010), even though the kinetics are
considerably faster than what would be expected if these recep-
tors were associated with endogenous CNIH-2. Yet there is
evidence suggesting that CNIH-2 can interact with AMPAR/g-8
complexes in the hippocampus (Kato et al., 2010). First, the level
of CNIH-2 is dramatically reduced in the g-8 knockout. Second,
AMPAR responses to the continuous application of glutamate do
not show resensitization unless g-8 is overexpressed, and
coexpression of CNIH-2 prevents this resensitization. These
data suggest that the lack of resensitization of AMPAR/g-8
complexes in hippocampal pyramidal neurons is attributable to
the presence of CNIH-2.
These results raise a number of questions. The results fromShi
et al. (2010) suggest that the role of CNIH-2 in neurons is more
consistent with that of an ER chaperone rather than a bona
fide auxiliary subunit. If so, it raises the intriguing question of
why CNIH-2 has such profound effects on the gating of
AMPARs. One possibility is that the salutary effects that gluta-
mate-induced conformational changes have on the biogenesis
of AMPARs (Coleman et al., 2009; Penn et al., 2008) may be
enhanced by CNIH-2, and the same could hold for TARPs. In
contrast to this model, Kato et al. (2010) present evidence that
a primary effect of CNIH-2 is to counteract the resensitization
of AMPAR/g-8 complexes. If this latter model is correct, then
AMPARs must normally be associated with both g-8 and
CNIH-2, contrary to the findings of Schwenk et al. (2009). This
model then raises a number of questions. If CNIH-2 is, in fact,
associated with AMPARs in hippocampal neurons, why are the
kinetics of native neurons much faster than would be expected
judging from data in heterologous cells? What is the mechanism
underlying resensitization and how does CNIH-2 prevent it?
What is the physiological role for resensitization, which requires
the continued application of glutamate for many seconds? In
addition, how is it that TARPs and CNIHs are so divergent
structurally and yet have common effects on AMPAR kinetics?
Hopefully many of these perplexing issues will be clarified byNeuron 70, April 28, 2011 ª2011 Elsevier Inc. 191
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deficient in CNIH-2.
Cystine-Knot AMPAR Modulating Protein
Cystine-knot AMPAR modulating protein (CKAMP44) was iden-
tified by a proteomic approach in which immunoprecipitation
and mass spectrometry of AMPAR complexes were used to
search for previously unknown AMPAR-interacting proteins
(von Engelhardt et al., 2010). CKAMP44 is a brain-specific type
I transmembrane protein that contains a cysteine-rich N-terminal
domain, likely forming a cystine knot similar to that in many
peptide toxins (Norton and Pallaghy, 1998) and the extracellular
domains of a diverse set of membrane proteins (Vitt et al., 2001).
It is widely expressed, though at modest levels, throughout the
brain with particularly robust expression in hippocampal dentate
granule cells. CKAMP44 interacts with all GluA subunits, and
AMPARs immunoprecipitated by CKAMP44 also contain
stargazin, suggesting that CKAMP44 and stargazin are pre-
sent within the same complexes. Furthermore, flag-tagged
CKAMP44 localizes to dendritic spines. Surprisingly, coexpres-
sion of CKAMP44 with GluA1–3 in Xenopus oocytes results
in a prominent reduction in glutamate-evoked currents without
any change in the amount of GluA protein measured by biotiny-
lation. A series of experiments in both oocytes and neurons
reach the remarkable conclusion that CKAMP44 prolongs deac-
tivation but accelerates desensitization. In addition, it slows the
rate of recovery from desensitization. These findings are in
striking contrast to those of both TARPs and CNIHs, which
both prolong deactivation and desensitization and accelerate,
or have no effect on, recovery from desensitization (von Engel-
hardt et al., 2010; Farrant and Cull-Candy, 2010; Guzman and
Jonas, 2010) (Table 1).
What consequencesmight the unique properties of CKAMP44
have on hippocampal function? To discern this, the authors
used overexpression of CKAMP44 in combination with
CKAMP44 KO mice. They first examined CA1 pyramidal
neurons, which express low levels of CKAMP44. They show
that overexpression slows the decay of mEPSCs and reduces
PPR, consistent with the slowing of recovery from desensitiza-
tion. Interestingly, in contrast to the effects of overexpression,
the CKAMP44 KO has no effect on EPSC kinetics, as might be
predicted by the low expression level. The authors repeated
these experiments in dentate granule neurons where CKAMP44
is expressed at high levels. Overexpression of CKAMP44 has no
effect on PPR, but in the KO, PPR is enhanced. It would be of
interest to know whether the decay of EPSCs in KO granule
neurons is accelerated as would be expected. These findings
are of considerable interest because, except for a few types of
synapses where the probability of release is high and/or multiple
active zones are present, desensitization is not thought to play
a prominent role in PPR (Silver and Kanichay, 2008). How
widespread might the role of CKAMP44 in the CNS be?
CKAM44 expression is especially high in the dentate gyrus
compared to many other regions of the brain, raising the possi-
bility that its role could be more restricted than that of TARPs.
It is not clear what advantagemay be conferred by having TARPs
andCKAMP44 interacting with the sameAMPAR, given that their
actions are antagonistic, at least in terms of their effects on
desensitization.192 Neuron 70, April 28, 2011 ª2011 Elsevier Inc.Synapse Differentially Induced Gene 1
Synapse differentially induced gene 1 (SynDIG1) is a candidate
AMPAR auxiliary subunit that was identified through application
of a microarray approach to the expression profile of the cere-
bella of lurcher mice, which show defects in neuronal differenti-
ation. One of the most highly differentially expressed genes was
SynDIG1 (Dı´az et al., 2002), which is upregulated during post-
natal development in wild-type, but not lurcher, cerebella.
SynDIG1 is a type II transmembrane protein that regulates
AMPAR content at developing hippocampal synapses (Kalashni-
kova et al., 2010). Immunocytochemical experiments in cultured
hippocampal neurons show that, while SynDIG1 clusters at
excitatory synapses, most clusters are nonsynaptic, but are
nonetheless associated with GluA2, suggesting that it might
bind to GluA2. Indeed, anti-SynDIG1 antibodies coimmunopre-
cipiate GluA2 from brain extracts and the two proteins cluster
on the surface of heterologous cells. This clustering requires
an intact extracellular C terminus of SynDIG1. Overepression
of SynDIG1 increases synapse density and increases the size
and fluorescent intensity of GluA1 puncta, but not NR1 puncta.
These anatomical changes are accompanied by an increase
in both the frequency and amplitude of AMPAR mEPSCs,
without a change in NMDAR mEPSCs. Thus both the immuno-
cytochemical and electrophysiological results suggest that
SynDIG1 selectively augments synaptic AMPAR content
(Table 1).
What do these overexpression experiments tell us about the
function of endogenous SynDIG1? To examine this, the authors
used short hairpin RNA (shRNA)-mediated knockdown of
endogenous SynDIG1. Indeed, SynDIG1 shRNA decreases the
density of GluA-containing synapses, and both the size and
fluorescent intensity of GluA clusters are also decreased. These
changes are accompanied by a reduction in AMPAR mEPSC
frequency and a dramatic reduction in mEPSC amplitude, but
again without a change in NMDAR mEPSCs. Interestingly, the
distribution of SynDIG1 at excitatory synapses is regulated by
activity. These intriguing findings indicate that SynDIG1 plays
an important function in the trafficking of AMPARs, but not
NMDARs, to synapses during development (Kalashnikova
et al., 2010; Dı´az, 2010a, 2010b). It will be of great interest to
determine if SynDIG1 shares other properties commonly attrib-
uted to auxiliary subunits—most importantly, modulation of
AMPAR gating. In addition, SynDIG1 has been proposed to
define a family of four genes in themouse, and it will be of interest
to see if these other family members act similarly to SynDIG1.
A Novel Transmembrane NMDAR Auxiliary Subunit
Neuropilin Tolloid-like 1
It hasbeen reported that neuropilin tolloid-like1 (NETO1), a single-
pass transmembrane protein with two extracellular CUBdomains
(Sto¨hr et al., 2002; Michishita et al., 2003) (Figures 4A and 4B),
interacts with NMDARs and is a candidate NMDAR auxiliary
subunit (Ng et al, 2009). NETO1 was found to coimmunoprecipi-
tate with GluN2A, GluN2B, and PSD-95 and is expressed in the
CA1 region of the hippocampus in addition to other brain regions.
Although the overall abundance ofGluN1,GluN2A, andGluN2B in
synaptosomal fractions is unchanged in theNETO1KOmouse, as
are the surface protein levels, there is a selective reduction in the
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Figure 4. Candidate iGluR Transmembrane
Auxiliary Subunits
(A) Bar diagrams showing the predicted domain
structures of four candidate iGluR transmembrane
auxiliary subunits. CNIH-2/3, CKAMP44, and
SynDIG1 have been shown to bind to and influ-
ence the trafficking and/or gating of AMPARs.
CNIH-2/3 is a small protein with three predicted
transmembrane domains. CKAMP44 has a single
transmembrane domain, a cysteine-rich extracel-
lular N-terminal domain (likely forming a cystine
knot), and a long intracellular CTD ending in a PDZ
binding motif. SynDIG1 also has only one pre-
dicted transmembrane domain with a C-terminal
hydrophobic region. NETO1 is a candidate
NMDAR auxiliary subunit, while NETO2 is a
candidate KAR auxiliary subunit. These homolo-
gous proteins are represented by one bar diagram,
which highlights the two large extracellular CUB
domains and a long CTD ending in a PDZ binding
motif.
(B) Illustration of the proposed secondary struc-
tures of the proteins shown in (A). Top is extra-
cellular, bottom is intracellular.
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tion in the amplitude of synaptic NMDAR currents, which was
accompanied by a decrease in the contribution of GluN2A-con-
taining receptors. Furthermore, LTP at Schaffer collateral-CA1
synapses and spatial learning are both impaired in the NETO1
KO mouse. Thus it is proposed that NETO1 is a component of
theNMDARcomplexand is involved in thedeliveryand/or stability
ofGluN2A-containingNMDARsatCA1synapses (Ng et al., 2009).
A Novel Transmembrane KAR Auxiliary Subunit
Neuropilin Tolloid-like 2
To identify novel transmembrane proteins that interact with
KARs, Tomita and colleagues carried out coimmunoprecipitation
experiments with cerebellar extracts followed by mass
spectrometry (Zhang et al., 2009). They identified neuropilin
tolloid-like 2 (NETO2), which, like NETO1, is a single-pass
transmembrane protein with two extracellular CUB domains
(Sto¨hr et al., 2002; Michishita et al., 2004) (Figures 4A and 4B).
In heterologous cells, NETO2 greatly enhances current through
GluK2 receptors, but not GluA1 receptors. NETO2 also increases
the efficacy of KA compared to glutamate in activating GluK2.
The enhancement occurs without any change in surface GluK2
protein. However, expression ofGluK2does enhance the surface
expression of NETO2. In cerebella from mice lacking GluK2, theNeuronlevels of NETO2 are reduced by 60%,
and much of this decrease is attributable
to the loss of surface NETO2. Similar to
the action of TARPs on AMPARs, NETO2
slows deactivation and desensitization
and speeds the recovery from desensiti-
zation of GluK2. To examine the possible
effects of NETO2 on synaptically evoked
KAR-mediated currents, a mutant of
GluK2 with reduced desensitization was
expressed in stargazer CGNs. When
NETO2 is coexpressed with this mutant,the frequency of mEPSCs increases and their time course is
slowed. Finally, to determine if NETO2 is normally associated
with KARs, the authors used shRNA to knock down endogenous
NETO2 in hippocampal neurons. They found that theKA/Glu ratio
of currents evoked by KARs is reduced with the knockdown of
NETO2.
These results raise a number of interesting questions. There
are a number of subunits that are involved in KAR function in
the brain. Does NETO2 have similar effects on the other types
of KARs? Does the related protein NETO1 also serve as a KAR
auxiliary subunit? Although the authors show that NETO2 can
slow the kinetics of synaptic currents generated by a mutated
GluK2, it will be of interest to knowwhat happens to well-charac-
terized KAR-mediated EPSCs when NETO2 is deleted. Further-
more, it is remarkable that NETO1 and NETO2, which are homol-
ogous to each other, act on entirely separate classes of iGluR.
Can NETO2 also act on NMDARs? Is it possible that NETO
proteins are auxiliary subunits for both KARs and NMDARs?
Clearly there is much to be resolved in this rapidly evolving area.
Concluding Remarks and Future Directions
Early studies on fast excitatory synaptic transmission in the brain
emphasized the stereotyped nature of excitatory synapses
whereby information is transmitted faithfully from one neuron70, April 28, 2011 ª2011 Elsevier Inc. 193
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Reviewto another. However, the discovery of synaptic plasticity and the
cloning of the various AMPAR subunit genes put this simplistic
view to rest. Importantly, receptors assembled from different
subunits have strikingly different biophysical properties. Add to
this the discovery that subunits exist as splice variants and can
undergo RNA editing, both of which control receptor gating,
and one begins to reach a daunting level of complexity. Given
this background one can reasonably wonder why AMPARs
and other iGluRs should need various auxiliary subunits and
the mind-boggling combinatorial possibilities that come with
these newly discovered proteins. Only further studies will shed
light on this general question.
There are, however, a number of specific and perhaps more
tractable questions that arise from this research. (1) Are all
surface iGluRs associated with auxiliary subunits? Although
most neuronal AMPARs studied thus far appear to be associated
with TARPs and perhaps other auxiliary subunits, it is unclear if
this association is required for functional surface receptors. For
C. elegans, auxiliary subunits are essential for functional recep-
tors, but this remains an open question for vertebrate AMPARs.
(2) How dynamic is the association of iGluRs and auxiliary
subunits? Although there is some evidence that prolonged
agonist application can dissociate TARPs from AMPARs, can
this occur under physiological conditions and with other iGluRs
and their auxiliary subunits? (3) How are so many proteins with
such little amino acid identity capable of modifying AMPAR
gating? Given this seeming lack of stringency, how many more
proteins remain tobediscovered that cancontrolAMPARgating?
Do they all act on the same site or sites? Do they all impose the
same conformational changes in the receptor? Only X-ray crys-
tallographic studies of AMPAR/auxiliary subunit complexes will
shed light on this problem. (4) What is the advantage of a neuron
expressing multiple auxiliary subunits? Can single iGluRs
assemble with multiple types of auxiliary subunit? (5) How does
the modulation of iGluR gating kinetics by auxiliary subunits
tune spatial and temporal integration in dendrites and action
potential timing? And is this modulation homeostatically regu-
lated in parallel with other mechanisms that determine EPSC
time course? (6) Might auxiliary subunits provide a target for
synaptic plasticity? Although considerable work suggests that
the C termini of AMPARs are important for plasticity, there is still
limited evidence that activity directly targets the AMPARs them-
selves. The key role auxiliary subunits play in controlling the shut-
tling of AMPAR from extrasynaptic to synaptic sites makes them
ideal targets for the activity-dependent control of AMPAR traf-
ficking. (7) Might auxiliary subunits play a role in neurological
and psychiatric disease? Genetic studies have provided tanta-
lizing hints, but thus far direct linkage is lacking. As is clear from
all the questions posed above, we are just beginning to appre-
ciate the importance of this exciting and rapidly expanding field.ACKNOWLEDGMENTS
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